| 000 | 01433 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250511235240.0 | ||
| 264 | 0 | _c19900806 | |
| 008 | 199008s 0 0 eng d | ||
| 022 | _a0006-291X | ||
| 024 | 7 |
_a10.1016/0006-291x(90)91999-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPelosin, J M | |
| 245 | 0 | 0 |
_aDifferential inhibition of protein kinase C subtypes. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cJun 1990 |
||
| 300 |
_a1040-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine |
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xpharmacology |
| 650 | 0 | 4 |
_aAdrenal Cortex _xenzymology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xenzymology |
| 650 | 0 | 4 |
_aGossypol _xpharmacology |
| 650 | 0 | 4 |
_aIsoquinolines _xpharmacology |
| 650 | 0 | 4 |
_aPhorbol 12,13-Dibutyrate _xmetabolism |
| 650 | 0 | 4 |
_aPhosphatidylserines _xpharmacology |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinase C _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 700 | 1 | _aKeramidas, M | |
| 700 | 1 | _aSouvignet, C | |
| 700 | 1 | _aChambaz, E M | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 169 _gno. 3 _gp. 1040-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0006-291x(90)91999-9 _zAvailable from publisher's website |
| 999 |
_c2369788 _d2369788 |
||